4-hydroxy-3-isopropyl-2H-chromen-2-one | 107058-05-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 4-hydroxy-3-isopropyl-2H-chromen-2-one
• 英文别名: 4-Hydroxy-3-isopropyl-cumarin；4-Hydroxy-3-(propan-2-yl)-2H-1-benzopyran-2-one；4-hydroxy-3-propan-2-ylchromen-2-one
• CAS: 107058-05-9
• 化学式: C₁₂H₁₂O₃
• 分子量: 204.225
• InChiKey: SADXQMGPTHOYEE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-羟基香豆素 、 异丙醇 在 iron perchlorate hexahydrate 作用下， 以 硝基甲烷 为溶剂， 反应 12.0h， 以67%的产率得到4-hydroxy-3-isopropyl-2H-chromen-2-one
  参考文献：
  名称：

  通过铁催化环化反应区域选择性地获得结构多样的香豆素类似物

  摘要：

  描述了一种高效的铁催化的炔丙基化/炔基羰基化/异构化策略。具有高区域选择性的生物活性呋喃[3,2- c ]香豆素和吡喃并[3,2- c ]香豆素被迅速组装。

  DOI：

  10.1002/ejoc.201700999

文献信息

• Materials and Methods for Treating Coagulation Disorders
  申请人：Druzgala Pascal

  公开号：US20080221204A1

  公开（公告）日：2008-09-11

  This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.

  本发明涉及化合物，这些化合物更容易被代谢药物解毒系统代谢。特别地，本发明涉及华法林类似物，其已被设计为在化合物的结构中包含酯基。本发明教导了在药物合成过程中引入酯基来减少药物毒性的方法。本发明还涉及治疗凝血障碍的方法，包括给予被设计为被血清或细胞内酯酶代谢的化合物。本发明还教导了含有酯基华法林类似物的药物组成物。
• Materials And Methods For Treating Coagulation Disorders
  申请人：Druzgala Pascal

  公开号：US20070129429A1

  公开（公告）日：2007-06-07

  This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.

  本发明涉及一种化合物，该化合物更易于被代谢药物解毒系统代谢。特别是，本发明教授了设计在化合物结构中包含酯基的华法林类似物。本发明教授了一种通过在药物合成过程中引入酯基来减少药物毒性的方法。本发明还涉及一种治疗凝血障碍的方法，该方法包括给予已经设计成可以被血清或细胞内水解酶和酯酶代谢的化合物。本发明还涉及含有酯基华法林类似物的制药组合物。
• Regioselective Access to Structurally Diverse Coumarin Analogues through Iron-Catalysed Annulation Reactions
  作者：Qiao Ren、Jie Kang、Muyao Li、Lujiang Yuan、Ruoyun Chen、Lei Wang

  DOI：10.1002/ejoc.201700999

  日期：2017.10.10

  A highly efficient iron-catalysed propargylation/alkyne oxacyclization/isomerization strategy is described. Biologically active furo[3,2-c]coumarins and pyrano[3,2-c]coumarins are expeditiously assembled with high regioselectivities.

  描述了一种高效的铁催化的炔丙基化/炔基羰基化/异构化策略。具有高区域选择性的生物活性呋喃[3,2- c ]香豆素和吡喃并[3,2- c ]香豆素被迅速组装。